-
1
Combining radiation with immune checkpoint inhibitors therapy for HCC: From the alteration of the immune microenvironment by radiotherapy
Published 2022-12-01Subjects: Get full text
Article -
2
Combining spatially fractionated radiation therapy (SFRT) and immunotherapy opens new rays of hope for enhancing therapeutic ratio
Published 2024-01-01Subjects: Get full text
Article -
3
Rheumatic immune-related adverse events from checkpoint inhibitor therapy: a case series
Published 2021-08-01Subjects: “…immune checkpoint inhibitors (icis)…”
Get full text
Article -
4
Risk Factors, Incidence, and Prognosis of Thromboembolism in Cancer Patients Treated With Immune Checkpoint Inhibitors
Published 2021-11-01Subjects: “…immune checkpoint inhibitors (ICIs)…”
Get full text
Article -
5
Sex-Related Differences in Immunotherapy Outcomes of Patients with Advanced Non-Small Cell Lung Cancer
Published 2024-11-01Subjects: Get full text
Article -
6
Metastatic pulmonary pleomorphic carcinoma replaced by a granulomatous lesion after spontaneous regression and PD-1 blockade-induced regression: can epithelioid granuloma be a hist...
Published 2023-04-01Subjects: “…Immune checkpoint inhibitors (ICIs)…”
Get full text
Article -
7
Impact of antibiotics on the efficacy of immune checkpoint inhibitors in the treatment of primary liver cancer
Published 2022-09-01Subjects: Get full text
Article -
8
Lenvatinib and immune-checkpoint inhibitors in hepatocellular carcinoma: mechanistic insights, clinical efficacy, and future perspectives
Published 2024-12-01Subjects: Get full text
Article -
9
Advances in sex disparities for cancer immunotherapy: unveiling the dilemma of Yin and Yang
Published 2022-10-01Subjects: Get full text
Article -
10
-
11
Clinical characteristics and potential biomarkers of thyroid and pituitary immune-related adverse events
Published 2024-01-01Subjects: Get full text
Article -
12
Anti-HER2 biparatopic antibody KJ015 has near-native structure, functional balanced high affinity, and synergistic efficacy with anti-PD-1 treatment in vivo
Published 2024-12-01Subjects: “…combination therapy with immune checkpoint inhibitors (ICIs)…”
Get full text
Article -
13
Evaluating distinct KRAS subtypes as potential biomarkers for immune checkpoint inhibitor efficacy in lung adenocarcinoma
Published 2023-10-01Subjects: Get full text
Article -
14
Combination therapy with immune checkpoint inhibitors (ICIs); a new frontier
Published 2022-01-01Subjects: “…Immune-checkpoint inhibitors (ICIs)…”
Get full text
Article -
15
Immunotherapy in melanoma: advances, pitfalls, and future perspectives
Published 2024-06-01Subjects: Get full text
Article -
16
Difficulty in differentiating liver injury from an immune checkpoint inhibitor from chemotherapy
Published 2024-08-01Subjects: “…immune checkpoint inhibitors (ICIs)…”
Get full text
Article -
17
Peptide self-assembled nanomedicine induces antitumor immunity by blocking the PD-1/PD-L1 axis
Published 2022-12-01Subjects: “…immune checkpoint inhibitors (ICIs)…”
Get full text
Article -
18
Effects of Concomitant Antibiotics Use on Immune Checkpoint Inhibitor Efficacy in Cancer Patients
Published 2022-02-01Subjects: Get full text
Article -
19
Immune Checkpoint Inhibitors and Vaccination: Assessing Safety, Efficacy, and Synergistic Potential
Published 2024-11-01Subjects: “…immune checkpoint inhibitors (ICIs)…”
Get full text
Article -
20